Results 1 to 10 of about 28,077 (207)

Systematic Review and Quality Evaluation Using ARRIVE 2.0 Guidelines on Animal Models Used for Periosteal Distraction Osteogenesis [PDF]

open access: yesAnimals, 2021
The objective of this systematic review was to synthesize all the preclinical studies carried out in periosteal distraction osteogenesis (PDO) in order to evaluate the quality using the ARRIVE guidelines.
Mario García-González   +4 more
doaj   +8 more sources

The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research [PDF]

open access: yesBMC Veterinary Research, 2020
Reproducible science requires transparent reporting. The ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments) were originally developed in 2010 to improve the reporting of animal research.
Nathalie Percie du Sert   +27 more
doaj   +41 more sources

Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. [PDF]

open access: yesPLoS Biology, 2020
Improving the reproducibility of biomedical research is a major challenge. Transparent and accurate reporting is vital to this process; it allows readers to assess the reliability of the findings and repeat or build upon the work of other researchers ...
Nathalie Percie du Sert   +27 more
doaj   +7 more sources

Explanation and Elaboration for the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅲ)

open access: yesShiyan dongwu yu bijiao yixue, 2023
Improving the reproducibility of biomedical research results is a major challenge.Researchers reporting their research process transparently and accurately can help readers evaluate the reliability of the research results and further explore the ...
LIU Xiaoyu   +12 more
doaj   +3 more sources

Reporting preclinical gene therapy studies in the field of Niemann-Pick type C disease according to the ARRIVE guidelines [PDF]

open access: yesOrphanet Journal of Rare Diseases
The lack of essential information when reporting animal studies causing lower reproducibility has been stressed for decades. The ARRIVE (Animal Research: Reporting of In Vivo Experiments) guidelines were first published in 2010, to improve reporting of ...
Charlotte Laurfelt Munch Rasmussen   +3 more
doaj   +4 more sources

Explanation and Elaboration for the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅳ)

open access: yesShiyan dongwu yu bijiao yixue, 2023
Improving the reproducibility of biomedical research results is a major challenge.Transparent and accurate reporting of the research process enables readers to evaluate the reliability of the research results and further explore the experiment by ...
LI Xiaying   +11 more
doaj   +3 more sources

Explanation and Elaboration for the ARRIVE Guidelines 2.0—Reporting Animal Research and In Vivo Experiments (Ⅰ)

open access: yesShiyan dongwu yu bijiao yixue, 2023
Improving the reproducibility of biomedical research results is a major challenge. Researchers reporting their research process transparently and accurately can help readers evaluate the reliability of the research results and further explore the ...
WANG Jian   +10 more
doaj   +2 more sources

Reporting quality of animal research in journals that published the ARRIVE 1.0 or ARRIVE 2.0 guidelines: a cross-sectional analysis of 943 studies. [PDF]

open access: yesCardiovasc Diagn Ther
The adherence to the Animals in Research: Reporting In Vivo Experiments (ARRIVE) guidelines across the journals that initially published the guidelines and if adherence has improved since the guidelines update, remains unknown. We aimed to quantify the level of adherence and analyze factors that might influence reporting quality among these journals ...
Lin Y   +10 more
europepmc   +3 more sources

Platelet-Rich Plasma in Veterinary Orthopedic Surgery: A Systematic Review and Quality Evaluation on Liquid- and Gel-Based Therapies in Dogs [PDF]

open access: yesGels
The clinical use of platelet-rich plasma (PRP) has gained increasing attention as a regenerative strategy in veterinary orthopedic surgery, yet its efficacy beyond osteoarthritis remains unclear.
Francisco Vidal-Negreira   +3 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy